Form 4: AtriCure Director Deborah H. Telman Acquires Shares Through Restricted Stock Award
SEC Form 4 Filing
Director Deborah H. Telman acquired 5,401 shares of AtriCure, Inc. common stock through a restricted stock award.
Summary
- On May 19, 2025, Deborah H. Telman, a director of AtriCure, Inc., acquired 5,401 shares of common stock.
- The acquisition was made through a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan.
- The shares will vest on the one-year anniversary of the grant date.
- Following the transaction, Telman directly owns 22,184 shares of AtriCure, Inc.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects a director's increased stake in the company, suggesting confidence. However, it's a routine transaction.
Positives
- The acquisition of shares by a director signals confidence in the company's future prospects.
- The Restricted Stock Award aligns the director's interests with those of the shareholders.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's performance and future prospects. This transaction reflects the director's investment in the company.
Stakeholder Impact
- The transaction could have a slightly positive impact on shareholders as it signals confidence from a company director.
Key Dates
| Date | Description |
|---|---|
| 05/19/2025 | Date of transaction: Deborah H. Telman acquired shares of AtriCure, Inc. common stock. |
| 05/21/2025 | Date of signature on the Form 4 filing. |
Keywords
AtriCure, Director, Stock Incentive Plan, Restricted Stock Award, Beneficial Ownership, Form 4, ATRC, Shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.